App

Over 24m doses of COVID-19 vaccine administered in China
Updated: January 31, 2021 20:41 Xinhua

BEIJING — More than 24 million doses of COVID-19 vaccine have been administered in China, the Chinese Center for Disease Control and Prevention said on Jan 31.

Preliminary tests showed that the incidence of severe abnormal reactions caused by the COVID-19 vaccines currently used in China is no higher than that of the influenza vaccine, Xu Wenbo, head of the National Institute for Viral Disease Control and Prevention under the center, said at a press conference held by the State Council joint prevention and control mechanism against COVID-19.

Last month, an inactivated vaccine developed by Beijing Biological Products Institute under the China National Biotec Group, affiliated with Sinopharm, became the first to receive conditional market approval from the National Medical Products Administration.

Copyright© www.gov.cn | About us | Contact us

Website Identification Code bm01000001 Registration Number: 05070218

All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to www.gov.cn.

Without written authorization from www.gov.cn, such content shall not be republished or used in any form.

Mobile

Desktop

Copyright© www.gov.cn | Contact us

Website Identification Code bm01000001

Registration Number: 05070218